These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 34673934)
1. A novel NUP98-JADE2 fusion in a patient with acute myeloid leukemia resembling acute promyelocytic leukemia. Cheng CK; Chan HY; Yung YL; Wan TSK; Leung AWK; Li CK; Tian K; Chan NPH; Cheung JS; Ng MHL Blood Adv; 2022 Jan; 6(2):410-415. PubMed ID: 34673934 [TBL] [Abstract][Full Text] [Related]
2. Alkaloid-based regimen is beneficial for acute myeloid leukemia resembling acute promyelocytic leukemia with NUP98/RARG fusion and RUNX1 mutation: A case report. Wei W; Liu Q; Song F; Cao H; Liu M; Jiang Y; Li Y; Gao S Medicine (Baltimore); 2020 Oct; 99(40):e22488. PubMed ID: 33019444 [TBL] [Abstract][Full Text] [Related]
3. Recurrent Osumi T; Tsujimoto SI; Tamura M; Uchiyama M; Nakabayashi K; Okamura K; Yoshida M; Tomizawa D; Watanabe A; Takahashi H; Hori T; Yamamoto S; Hamamoto K; Migita M; Ogata-Kawata H; Uchiyama T; Kizawa H; Ueno-Yokohata H; Shirai R; Seki M; Ohki K; Takita J; Inukai T; Ogawa S; Kitamura T; Matsumoto K; Hata K; Kiyokawa N; Goyama S; Kato M Cancer Res; 2018 Aug; 78(16):4452-4458. PubMed ID: 29921692 [TBL] [Abstract][Full Text] [Related]
4. A novel NPM1-RARG-NPM1 chimeric fusion in acute myeloid leukaemia resembling acute promyelocytic leukaemia but resistant to all-trans retinoic acid and arsenic trioxide. Chen X; Wang F; Zhang Y; Teng W; Cao P; Ma X; Liu M; Tian Y; Wang T; Nie D; Zhang J; Liu H; Wang W Br J Cancer; 2019 May; 120(11):1023-1025. PubMed ID: 30996344 [TBL] [Abstract][Full Text] [Related]
5. Clinical and genomic characterization of an ATRA-insensitive acute promyelocytic leukemia variant with a FNDC3B::RARB fusion. Kirkham JK; Liu YC; Foy SG; Ma J; Gheorghe G; Furtado LV; Popescu MI; Klco JM; Karol SE; Blackburn PR Genes Chromosomes Cancer; 2023 Oct; 62(10):617-623. PubMed ID: 37283355 [TBL] [Abstract][Full Text] [Related]
6. Acute Myeloid Leukemia with Tao S; Song L; Deng Y; Chen Y; Shi Y; Gan Y; Deng Z; Ding B; He Z; Wang C; Yu L Onco Targets Ther; 2020; 13():10559-10566. PubMed ID: 33116634 [TBL] [Abstract][Full Text] [Related]
7. A novel NUP98/RARG gene fusion in acute myeloid leukemia resembling acute promyelocytic leukemia. Such E; Cervera J; Valencia A; Barragán E; Ibañez M; Luna I; Fuster O; Perez-Sirvent ML; Senent L; Sempere A; Martinez J; Martín-Aragonés G; Sanz MA Blood; 2011 Jan; 117(1):242-5. PubMed ID: 20935257 [TBL] [Abstract][Full Text] [Related]
9. RARA and RARG gene downregulation associated with EZH2 mutation in acute promyelocytic-like morphology leukemia. Coccaro N; Zagaria A; Orsini P; Anelli L; Tota G; Casieri P; Impera L; Minervini A; Minervini CF; Cumbo C; Parciante E; Mestice A; Delia M; Brunetti C; Specchia G; Albano F Hum Pathol; 2018 Oct; 80():82-86. PubMed ID: 29530751 [TBL] [Abstract][Full Text] [Related]
10. Report of PRPF19 as a novel partner of RARG and the recurrence of interposition-type fusion in variant acute promyelocytic leukemia. Wu H; Li H; Zhou X; Zhao Z; Cao P; Li L; Ma X; Yuan L; Wang F; Zhang Y; Chen J; Fang J; Liu M; Liu M; Chen X; Liu H Hematol Oncol; 2023 Oct; 41(4):784-788. PubMed ID: 37132198 [TBL] [Abstract][Full Text] [Related]
11. A short report of novel Song Y; Hou J; Wan L; Liu K; Zhou C; Wei S; Zhang G; Lin D; Li Y; Fang Q; Liu Y; Gong B; Gong X; Wang Y; Wei H; Wang J; Mi Y Hematology; 2022 Dec; 27(1):518-522. PubMed ID: 35544458 [TBL] [Abstract][Full Text] [Related]
12. Mutational profile of ZBTB16-RARA-positive acute myeloid leukemia. Fabiani E; Cicconi L; Nardozza AM; Cristiano A; Rossi M; Ottone T; Falconi G; Divona M; Testi AM; Annibali O; Castelli R; Lazarevic V; Rego E; Montesinos P; Esteve J; Venditti A; Della Porta M; Arcese W; Lo-Coco F; Voso MT Cancer Med; 2021 Jun; 10(12):3839-3847. PubMed ID: 34042280 [TBL] [Abstract][Full Text] [Related]
13. Novel treatment of acute promyelocytic leukemia: As₂O₃, retinoic acid and retinoid pharmacology. Zhu G Curr Pharm Biotechnol; 2013; 14(9):849-58. PubMed ID: 24433507 [TBL] [Abstract][Full Text] [Related]
14. BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia. Yamamoto Y; Tsuzuki S; Tsuzuki M; Handa K; Inaguma Y; Emi N Blood; 2010 Nov; 116(20):4274-83. PubMed ID: 20807888 [TBL] [Abstract][Full Text] [Related]
15. Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia. Chim CS; Wong SY; Pang A; Chu P; Lau JS; Wong KF; Kwong YL Leukemia; 2005 Dec; 19(12):2241-6. PubMed ID: 16239915 [TBL] [Abstract][Full Text] [Related]
16. The molecular biology of acute promyelocytic leukemia. Slack JL; Gallagher RE Cancer Treat Res; 1999; 99():75-124. PubMed ID: 9891864 [TBL] [Abstract][Full Text] [Related]
17. Acute Promyelocytic Leukemia with Rare Genetic Aberrations: A Report of Three Cases. Liu G; Liu L; Bartolo DD; Li KY; Li X Genes (Basel); 2022 Dec; 14(1):. PubMed ID: 36672788 [TBL] [Abstract][Full Text] [Related]
18. Growth suppression of acute promyelocytic leukemia cells having increased expression of the non-rearranged alleles: RAR alpha or PML. Ahn MJ; Nason-Burchenal K; Moasser MM; Dmitrovsky E Oncogene; 1995 Jun; 10(12):2307-14. PubMed ID: 7784078 [TBL] [Abstract][Full Text] [Related]
19. C/EBPbeta: a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells. Duprez E; Wagner K; Koch H; Tenen DG EMBO J; 2003 Nov; 22(21):5806-16. PubMed ID: 14592978 [TBL] [Abstract][Full Text] [Related]
20. Acute promyelocytic leukemia: from clinic to molecular biology. Chen SJ; Wang ZY; Chen Z Stem Cells; 1995 Jan; 13(1):22-31. PubMed ID: 7719245 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]